- Home
- BAK vs CERT Comparison
BAK vs CERT Comparison
Compare BAK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAK
- CERT
- Stock Information
- Founded
- BAK 1972
- CERT 2008
- Country
- BAK Brazil
- CERT United States
- Employees
- BAK N/A
- CERT N/A
- Industry
- BAK Major Chemicals
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- BAK Industrials
- CERT Technology
- Exchange
- BAK Nasdaq
- CERT Nasdaq
- Market Cap
- BAK 1.7B
- CERT 1.8B
- IPO Year
- BAK N/A
- CERT 2020
- Fundamental
- Price
- BAK $4.17
- CERT $11.66
- Analyst Decision
- BAK Strong Buy
- CERT Buy
- Analyst Count
- BAK 3
- CERT 7
- Target Price
- BAK $9.75
- CERT $15.92
- AVG Volume (30 Days)
- BAK 958.6K
- CERT 1.0M
- Earning Date
- BAK 11-06-2024
- CERT 02-27-2025
- Dividend Yield
- BAK N/A
- CERT N/A
- EPS Growth
- BAK N/A
- CERT N/A
- EPS
- BAK N/A
- CERT N/A
- Revenue
- BAK $13,764,416,401.00
- CERT $372,797,000.00
- Revenue This Year
- BAK $14.98
- CERT $10.20
- Revenue Next Year
- BAK $8.32
- CERT $10.01
- P/E Ratio
- BAK N/A
- CERT N/A
- Revenue Growth
- BAK 2.86
- CERT 5.62
- 52 Week Low
- BAK $3.69
- CERT $9.41
- 52 Week High
- BAK $10.98
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- BAK 49.28
- CERT 57.94
- Support Level
- BAK $3.69
- CERT $10.46
- Resistance Level
- BAK $4.03
- CERT $12.21
- Average True Range (ATR)
- BAK 0.15
- CERT 0.57
- MACD
- BAK 0.09
- CERT 0.09
- Stochastic Oscillator
- BAK 89.20
- CERT 71.20
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.